- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 30 Years - NA Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All
My publications
Filter publications
241 publications
2024
Interstitial Lung Disease as an Emerging Contributor to Mortality in Patients With Inflammatory Bowel Disease: A Population-Based Epidemiological Study
Clinical and Translational Gastroenterology
•2024
Investigating Metabolic Phenotypes for Sarcoidosis Diagnosis and Exploring Immunometabolic Profiles to Unravel Disease Mechanisms.
Metabolites
•2024
Nonsurgical Treatment for Symptomatic Pulmonary Aspergilloma. Reply to Han and Kher: Treatment of Simple Pulmonary Aspergilloma
ATS Scholar
2024
Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
European respiratory review : an official journal of the European Respiratory Society
•2024
Proposing the potential of utilizing the CAT score for early detection of COPD in asymptomatic patients, shifting towards a patient-centered approach: A review
Medicine